Aim To investigate biosynthesis in nitric oxide (NO) during normal pregnancy and in pregnancies complicated by preeclampsia. Methods This prospective cross-sectional study included 80 patients hospitalized at the Department of Women's Health, Neonatology and Perinatology Cantonal Hospital in Zenica. Serum NO concentration in 20 non-pregnant women, 40 healthy pregnant women and 20 pregnant women with preeclampsia aged 17-40 years were measured. The group of healthy pregnant women were divided into 4 subgroups by gestational age. For each woman with preeclampsia, a healthy pregnant control was matched for age, parity and gestational age. Serum NO concentrations were determined after reduction of nitrates to nitrites using the Griess reaction. Results NO concentrations during second trimester of pregnancy (37.2±1.7µM; p<0.05) and third trimester of pregnancy (40.9±2.8μM; p<0.05) were significantly higher in healthy pregnant women than in non-pregnant women (29.3±1.7μM). Serum NO concentrations were lower in preeclamptic women (30.7±1.8μM) compared to matched healthy pregnant women of the third and the late third trimester (35.1±2.2μM), without significant differences. Mean NO concentrations in pre-eclamptic women was positively correlated with systolic blood pressure (r=0.58; p<0.01), diastolic blood pressure (r=0.45; p<0.05), creatinine clearance (r=0.48; p<0.05), uric acid (r=0.49; p<0.05), and negatively correlated with platelet count (r=-0.57; p<0.05). Conclusion NO production was increased with gestational age during normal pregnancy and slightly decreased in preeclampsia suggesting that NO may modulate the cardiovascular changes during normal pregnancy and pregnancy complicated by preeclampsia.
Cameron I, Van Papendorf C, Palmer R, Smith S, Moncada S. Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens Pregnancy 1993:85–92.
Paşaoğlu H, Bulduk G, Oğüş E, Paşaoğlu A, Onalan G. Nitric oxide, lipid peroxides, and uric acid levels in pre-eclampsia and eclampsia. Tohoku J Exp Med 2004:87–92.
6
Mackenzie I, Ekangaki A, Young D, Garrard C. Effect of renal function on serum nitrogen oxide concentrations. Clin Chem 1996:440–4.
7
Owusu B, Stapley R, Honavar J, Patel R. Effects of erythrocyte aging on nitric oxide and nitrite metabolism. Antioxid Redox Signal 2013:1198–208.
8
Brennecke S, Gude N, Iulio D, King J, R. Reduction of placental nitric oxide synthase activity in pre-eclampsia. Clin Sci 1997:51–5.
9
Lyall F, Young A, Greer I. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 1995:714–8.
10
Mabbott N, Sternberg J. Bone marrow nitric oxide production and development of anemia in Trypanosoma brucei-infected mice. Infect Immun 1995:1563–6.
11
Ni Z, Morcos S, Vaziri N. Up-regulation of renal and vascular nitric oxide synthase in iron deficiency anemia. Kidney Int 1997:195–201.
12
Choi J, Pai S, Kim S, Ito M, Park C, Cha Y. Iron deficiency anemia increases nitric oxide production in healthy adolescents. Ann Hematol 2002:1–6.
13
Bryan N, Grisham M. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med 2007:645–57.
14
Green L, Wagner D, Glogowski J, Skipper P, Wishnok J, Tannenbaum S. Analysis of nitrate, nitrite and 15N nitrate in biological fluids. Anal Biochem 1982:131–8.
15
Report on high blood pressure in pregnancy. Am J Obstet Gynecol 2000:1–22.
16
Filho A, B, Da Costa P, Ogando B, Vieira P, M, et al. Poli-de-Figueiredo CE. Serum nitrate and NOx levels in preeclampsia are higher than in normal pregnancy. Hypertens Pregnancy 2016:226–33.
17
Wedel J, Mandala M, Barron C, Bernstein I, Osol G. Mechanisms underlying maternal venous adaptation in pregnancy. Reprod Sci 2009:596–604.
18
Davidge S, Stranko C, Roberts J. Urine but not plasma nitric oxide metabolites are decreased in women with preeclampsia. Am J Obstet Gynecol 1996:1008–13.
19
Zeng Y, Li M, Chen, Homocysteine W. endothelin-1 and nitric oxide in patients with hypertensive disorders complicating pregnancy. Int J Clin Exp Pathol 2015:15275–9.
20
Matsubara K, Matsubara Y, Hyodo S, Katayama T, Ito M. Role of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. J Obstet Gynaecol Res 2010:239–47.
21
Su J. Vascular endothelial dysfunction and pharmacological treatment. World J Cardiol 2015:719–41.
22
Poon L, Kametas N, Chelemen T, Leal A, Nicolaides K. Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. J Hum Hypertens 2010:104–10.
23
Make every mother and child count. The world health report. Geneva 2005.
24
Carty D, Delles C, Dominiczak A. Preeclampsia and future maternal health. J Hypertens 2010:1349–55.
25
Smarason A, Allman K, Young D, Redman C. Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with pre-eclampsia. Br J Obstet Gynaecol 1997:538–43.
26
Brown M, Tibben E, Zammit V, Cario G, Carlton M. Nitric oxide excretion in normal and hypertensive pregnancies. Hypertens Pregnancy 1995:319–26.
27
Hata T, Hashimoto M, Kanenishi K, Akiyama M, Yanagihara T, Masumura S. Maternal circulation nitrite levels are decreased in both normal normotensive pregnancies and pregnancies with preeclampsia. Gynecol Obstet Invest 1999:93–7.
28
Shaamash A, Elsnosy E, Makhlouf A, Zakhari M, Ibrahim O. EL-dien HM. Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2000:207–14.
29
Choi J, Im M, Pai S. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Ann Clin Lab Sci 2002:257–63.
30
Poniedziałek-Czajkowska E, Marciniak B, Kimber-Trojnar Z, Leszczyńska-Gorzelak B, Oleszczuk J. Nitric oxide in normal and preeclamptic pregnancy. Curr Pharm Biotechnol 2011:743–9.
31
Valdes G, Kaufmann P, Corthorn J, Erices R, Brosnihan K, Joyner-Grantham J. Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod Biol Endocrinol 2009:79.
32
Leo C, Jelinic M, Ng H, Marshall S, Novak J, Tare M, et al. Vascular actions of relaxin: nitric oxide and beyond. Br J Pharmacol 2017:1002–14.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
